[Mucopolysaccharidosis: A review].
Michaud M, Belmatoug N, Catros F, Ancellin S, Touati G, Levade T, Gaches F.
Rev Med Interne. 2020 Mar;41(3):180-188. doi: 10.1016/j.revmed.2019.11.010. Epub 2020 Jan 17.
Mucopolysaccharidosis: A broad review.
Nagpal R, Goyal RB, Priyadarshini K, Kashyap S, Sharma M, Sinha R, Sharma N.
Indian J Ophthalmol. 2022 Jul;70(7):2249-2261. doi: 10.4103/ijo.IJO_425_22.
[Mucopolysaccharidosis: clinical features, diagnosis and management].
Suarez-Guerrero JL, Gómez Higuera PJ, Arias Flórez JS, Contreras-García GA.
Rev Chil Pediatr. 2016 Jul-Aug;87(4):295-304. doi: 10.1016/j.rchipe.2015.10.004. Epub 2015 Nov 21.
Mucopolysaccharidosis III: Molecular basis and treatment.
Spahiu L, Behluli E, Peterlin B, Nefic H, Hadziselimovic R, Liehr T, Temaj G.
Pediatr Endocrinol Diabetes Metab. 2021;27(3):201-208. doi: 10.5114/pedm.2021.109270.
Spine challenges in mucopolysaccharidosis.
Crostelli M, Mazza O, Mariani M, Mascello D, Iorio C.
Int Orthop. 2019 Jan;43(1):159-167. doi: 10.1007/s00264-018-4143-0. Epub 2018 Sep 14.
Recent trends in mucopolysaccharidosis research.
Kobayashi H.
J Hum Genet. 2019 Feb;64(2):127-137. doi: 10.1038/s10038-018-0534-8. Epub 2018 Nov 19.
Mucopolysaccharidosis-Plus Syndrome.
Vasilev F, Sukhomyasova A, Otomo T.
Int J Mol Sci. 2020 Jan 9;21(2):421. doi: 10.3390/ijms21020421.
Mucopolysaccharidosis.
Danos O, Heard JM.
Mol Cell Biol Hum Dis Ser. 1995;5:350-67. doi: 10.1007/978-94-011-0547-7_17.
Epilepsy in mucopolysaccharidosis disorders.
Scarpa M, Lourenço CM, Amartino H.
Mol Genet Metab. 2017 Dec;122S:55-61. doi: 10.1016/j.ymgme.2017.10.006. Epub 2017 Oct 16.
Has resveratrol a potential for mucopolysaccharidosis treatment?
Rintz E, Pierzynowska K, Podlacha M, Węgrzyn G.
Eur J Pharmacol. 2020 Dec 5;888:173534. doi: 10.1016/j.ejphar.2020.173534. Epub 2020 Aug 30.
